4
Changes in Ownership
Oncotelic Therapeutics, Inc. Filed Acc 0001493152-25-024236
Options or other derivatives
- CHAIRMAN AND CEO acquired 4,065 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Trieu Vuong CHAIRMAN AND CEO | 2025-11-17 | Grant or award · Series A Convertible Preferred Stock | +4,065 | 4,065 | D | ||
Loading xslF345X05/ownership.xml…